http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112574145-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-66 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2020-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112574145-B |
| titleOfInvention | Furanone-based amino acid compound and its preparation method and application as blood coagulation drug |
| abstract | The invention discloses a furanone-based amino acid compound, a preparation method and an application as a blood coagulation drug. The structural formula of the furanone-based amino acid compound of the present invention is: In the formula, X is selected from one of -Cl and -Br, R 1 is selected from one of C 3 -C 10 alkyl groups and C 6 -C 10 aryl groups, and R 2 is selected from one of the. The preparation method of the furanone-based amino acid compound of the present invention comprises the following steps: reacting tranexamic acid, aminotoluic acid or aminocaproic acid with the 2(5H)-furanone compound to obtain the furanone-based amino acid compound. The furanone-based amino acid compound of the present invention has excellent coagulation performance, short coagulation time, simple preparation method, mild reaction conditions, and simple post-processing operation, and is expected to be used in clinic as a multifunctional drug for coagulation, anti-inflammatory and pain relief. |
| priorityDate | 2020-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.